Legal Representation
Attorney
Cheryl L. Foytlin
USPTO Deadlines
Next Deadline
148 days remaining
NOA E-Mailed - SOU Required
Due Date
December 03, 2025
Extension Available
Until June 03, 2026
Application History
9 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 3, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 13, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 13, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 3, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 3, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Feb 3, 2025 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders
Classification
International Classes
005